HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norifumi Sawamukai Selected Research

Infliximab (Remicade)

3/2014Efficacy and safety of reducing duration of infliximab infusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norifumi Sawamukai Research Topics

Disease

11Rheumatoid Arthritis
04/2019 - 11/2007
1Inflammation (Inflammations)
07/2015
1Systemic Scleroderma (Systemic Sclerosis)
07/2015
1Pathologic Processes
11/2013
1Neoplasms (Cancer)
06/2012
1Sjogren's Syndrome (Sjogren Syndrome)
12/2003

Drug/Important Bio-Agent (IBA)

3Abatacept (Orencia)FDA Link
01/2018 - 01/2014
2Adalimumab (Humira)FDA Link
02/2015 - 09/2013
1Biological ProductsIBA
04/2019
1Antirheumatic Agents (DMARD)IBA
04/2019
1Tumor Necrosis Factor InhibitorsIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016
13-benzoyl dopamine (MBDA)IBA
11/2016
1Biomarkers (Surrogate Marker)IBA
11/2016
1Histamine (Histamine Dihydrochloride)FDA Link
07/2015
1AA amyloidosisIBA
05/2014
1tocilizumab (atlizumab)FDA Link
05/2014
1Amyloid (Amyloid Fibrils)IBA
05/2014
1Infliximab (Remicade)FDA Link
03/2014
1Tolonium ChlorideFDA Link
11/2013
1anti-scl-70 autoantibodiesIBA
11/2013
1Tacrolimus (Prograf)FDA LinkGeneric
03/2010
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2010
1Calcineurin InhibitorsIBA
03/2010
1Leflunomide (Arava)FDA LinkGeneric
11/2007
1Pharmaceutical PreparationsIBA
11/2007
1mizoribineIBA
12/2003

Therapy/Procedure

2Therapeutics
04/2019 - 06/2012